GLPwatch
Papers (12034)
Page 127 of 201, ranked by citation count.
- Treatment of obesity: will incretin agonists make bariatric surgery a thing of the past?
- Chemical chaperone-conjugated exendin-4 as a cytoprotective agent for pancreatic β-cells.
- The Influence of Liraglutide for Heart Failure: A Meta-Analysis of Randomized Controlled Trials.
- A comprehensive review on liraglutide and novel nanocarrier-based systems for the effective delivery of liraglutide.
- Glucagon-like pepetide-1 receptor agonist suggests novel therapeutic options for hypothalamic obesity.
- Repeated Withdrawal of a GLPR Agonist Induces Hyperleptinemia and Deteriorates Metabolic Health in Obese Aging UM-HET3 Mice.
- Improved Glycemic Control and Vascular Function and Reduction of Abdominal Fat Accumulation with Liraglutide in a Case of Werner Syndrome with Diabetes Mellitus.
- Evaluation of the Use of Exenatide Once-Weekly Suspension Autoinjector Among Patients With Type 2 Diabetes Mellitus and Health Care Professionals.
- Exenatide induced acute kidney injury.
- Liraglutide vs. sitagliptin add-on to metformin treatment for type 2 diabetes mellitus: Short-term cost-per-controlled patient in Italy.
- Real-World Alcohol Use Disorder Outcomes in Patients With Concurrent Metabolic Dysfunction: GLP-1 Receptor Agonists Versus FDA-Approved AUD Medications.
- Exploring the Effects of Tirzepatide on Obstructive Sleep Apnea: A Literature Review.
- Oral Semaglutide, A New Option in the Management of Type 2 Diabetes Mellitus: A Narrative Review.
- GLP-1 receptor agonists and preconception planning: bridging the gap between obesity treatment and reproductive safety, a narrative review.
- The effects of GLP-1 agonists on HbA1c and insulin dose among patients with type 1 diabetes.
- Tirzepatide reduces alcohol drinking and relapse-like behaviours in rodents.
- Who Wins the Battle Against Obesity? A Network Meta-Analysis Comparing Tirzepatide and Semaglutide.
- Tirzepatide 5, 10 and 15 mg versus injectable semaglutide 0.5 mg for the treatment of type 2 diabetes: An adjusted indirect treatment comparison.
- Efficacy of Tirzepatide Dual GIP/GLP-1 Receptor Agonist In Patients with Idiopathic Intracranial Hypertension. A Real-World Propensity Score-Matched Study.
- Gastric ultrasound in patients receiving semaglutide: a prospective, multicentre, matched control study.
- Contractile effects of retatrutide in isolated mouse atrial preparations.
- Dosing Patterns of Dulaglutide and Semaglutide in Patients with Type 2 Diabetes in the United Kingdom and Germany: A Retrospective Cohort Study.
- Exenatide stimulates solute-free water clearance by the rat kidney in hyperhydration.
- Exploring omics signature in the cardiovascular response to semaglutide: Mechanistic insights and clinical implications.
- Effectiveness, Safety, and Patient Satisfaction of Liraglutide in Type 2 Diabetic Patients.
- Long-acting hydrogel-based depot formulations of tirzepatide and semaglutide for the management of type 2 diabetes and weight.
- Real-world impact of tirzepatide on the risk of progression to type 2 diabetes and metabolic outcomes in people with obesity and pre-diabetes.
- Anti-inflammatory effect of glucagon-like Peptide-1 receptor agonist on the neurosensory retina in an acute optic nerve injury rat model.
- Dypeptidylpeptidase-4 inhibitors and the cardiovascular system: How to manage the fil rouge.
- Real-World Safety Concerns of Tirzepatide: A Retrospective Analysis of FAERS Data (2022-2025).
- Unraveling the impact of semaglutide in a diabetic rat model of testicular dysfunction: Insights into spermatogenesis pathways and miRNA-148a-5p.
- A treat-to-target approach for obesity management: A post hoc analysis of the SURMOUNT-5 trial.
- Pharmacokinetics and Preliminary Pharmacodynamics of Single- and Multiple-dose Lyophilized Recombinant Glucagon-like Peptide-1 Receptor Agonist (rE-4) in Chinese Patients with Type 2 Diabetes Mellitus.
- Target Trial Emulations of GLP-1 and Dual GLP-1/GIP Agonists to Reduce Major Adverse Liver Outcomes in Type 2 Diabetes.
- A Case of Dulaglutide-Induced Vaginal Bleed.
- Switching From Daily DPP-4 Inhibitor to Once-Weekly GLP-1 Receptor Activator Dulaglutide Significantly Ameliorates Glycemic Control in Subjects With Poorly Controlled Type 2 Diabetes Mellitus: A Retrospective Observational Study.
- Short- and long-acting GLP-1 receptor agonists decrease female sexual behaviors in experienced rodents.
- Liraglutide Ameliorates Renal Endothelial Dysfunction in Diabetic Rats Through the Inhibition of the Dll4/Notch2 Pathway.
- Effectiveness, Safety, and Appropriateness in the Use of the Fixed-Ratio Combination of Insulin Glargine and Lixisenatide in Type 2 Diabetes: The ENSURE Retrospective Real-World Study.
- Semaglutide-Associated Gastric Pneumatosis.
- Editorial: Reviews and Novel Clinical Perspectives on Semaglutide: A GLP-1 Receptor Agonist With Both Injectable and Oral Formulations.
- ACTUALITIES IN ENDOCRINE PHARMACOLOGY: ADVANCES IN THE DEVELOPMENT OF ORAL FORMULATIONS FOR CALCITONIN AND SEMAGLUTIDE.
- Neuroprotective effects of lixisenatide against propagation of α-synuclein pathology in Parkinson's disease.
- Combination exenatide-sitagliptin therapy used with glipizide in a patient with type 2 diabetes mellitus.
- Protective Effect of Semaglutide on Obesity-Induced Renal Disease and Obesity-Induced Kidney Renal Clear Cell Carcinoma.
- The Effects of Semaglutide on Inflammation and Immune Activation in HIV-associated Lipohypertrophy.
- Effects of exenatide and liraglutide on postchallenge glucose disposal in individuals with normal glucose tolerance.
- Tirzepatide reverses hypothalamic inflammation, cellular stress, and neuropeptide imbalance in metabolic-menopausal dysfunction.
- The combination of a glucagon-like peptide-1 and amylin receptor agonists reduces alcohol consumption in both male and female rats.
- A feasibility study of the combination of intranasal insulin with dulaglutide for cognition in older adults with metabolic syndrome at high dementia risk - Study rationale and design.
- Comparative efficacy and safety of weekly dulaglutide versus weekly insulin in type 2 diabetes: A network meta-analysis of randomized clinical trials.
- Glycemic variability in type 2 diabetes mellitus and acute coronary syndrome: liraglutide compared with insulin glargine: a pilot study.
- Glucagon-like peptide-1 receptor agonist exenatide has no acute effect on MRI-measured exocrine pancreatic function in patients with type 2 diabetes: a randomized trial.
- Semaglutide-induced Wernicke encephalopathy: a comprehensive analysis.
- HOMA-S is associated with greater HbA1c reduction with a GLP-1 analogue in patients with type 2 diabetes.
- Cost per Patient Achieving Treatment Targets and Number Needed to Treat with Tirzepatide Versus Semaglutide 1 mg in Patients with Type 2 Diabetes in the United States.
- Blinded by the drug? A vigilyze signal linking semaglutide to NAION.
- Cost-effectiveness analysis of four glucagon-like peptide-1 or glucose-dependent insulinotropic polypeptide/glucagon-like peptide-1 receptor agonists for the treatment of adult patients with overweight and obesity in China.
- Efficacy of tirzepatide for weight loss and it's comparative effectiveness to weight loss surgery in inflammatory bowel disease.
- Oral glucose-stimulated serum C-peptide predicts successful switching from insulin therapy to liraglutide monotherapy in Japanese patients with type 2 diabetes and renal impairment.